Skip to main content
Download PDF

Porcine placenta hydrolysates enhance osteoblast differentiation through their antioxidant activity and effects on ER stress

BMC Complementary and Alternative Medicine volume 16, Article number: 291 (2016) Cite this article

Abstract

Background

Osteoporosis is a disease characterized by decreased bone strength, decreased bone mass, and bone deterioration. Oxidative damage is an important contributor to functional changes in the development of osteoporosis. Here we found that porcine placenta hydrolysates (PPHs) protect MC3T3-E1 osteoblastic cells against hydrogen peroxide (H2O2)-induced oxidative damage.

Methods

In vitro cell viability was determined using trypan blue dye exclusion. ER stress and apoptosis were evaluated using immunoblotting and a commercially available caspase kit. ALP, osteocalcin, Runx2, and osterix expression levels were evaluated by RT-PCR using isolated RNA. ROS, NADPH oxidase, and SOD activity levels were also measured.

Results

We investigated the mechanisms underlying PPH-mediated inhibition of H2O2-induced ER stress and ROS production. PPHs also regulated osteoblast differentiation via the upregulation of alkaline phosphatase (ALP) expression in MC3T3-E1 osteoblastic cells. Also, treatment with PPHs enhanced the transcription of osteocalcin, Runx2, and osterix. These effects were all associated with the antioxidant actions of PPHs. Moreover, PPHs reversed the decrease in SOD activity, decreased ROS release, and inhibited NADPH oxidase activity in H2O2-treated MC3T3-E1 osteoblastic cells.

Conclusions

PPHs protect cells against H2O2-induced cell damage when ER stress is involved. In addition, PPHs enhance osteoblast differentiation. This enhancement likely explains the regulatory effect of PPHs on bone metabolism disturbances, i.e. PPHs control ER stress and the related ROS production in osteoblasts.

Peer Review reports

Background

Osteoporosis is characterized by decreased bone strength, decreased bone mass, and bone tissue deterioration. An imbalance between bone resorption and bone formation is the dominant mechanism causing osteoporosis [1, 2]. Since new bone formation primarily depends on osteoblasts, factors that disturb their bone-forming characteristics can lead to bone formation defects or related pathological conditions. Osteoblasts are secretory cells with well-developed endoplasmic reticulum (ER) cristae, in which many secretory proteins are folded and then secreted. The balance of osteoblasts and osteoclastic cells is carefully controlled to maintain bone and the related endocrinology homeostasis [1, 3, 4]. ROS are one of the key factors responsible for dysregulation of bone maintenance, especially osteoblast physiology. Osteoblasts are coated with high levels of secreted proteins. When these cells do not work effectively, ROS affect the secretory function of the osteoblasts, resulting in detrimental signaling to osteoclasts. Furthermore, during severe pathologic stress, osteoblasts undergo apoptosis. This also disturbs the balance between osteoblasts and osteoclasts and ultimately leads to bone resorption and related disease conditions [5].

The ER plays a major role in controlling protein folding and secretion in cells. Various acute and chronic conditions, including protein misfolding and Ca2+ disturbances, can alter ER function and lead to ER stress [6–8]. Furthermore, ER stress has been reported to contribute to several diseases, including many bone diseases [9, 10]. Osteoblast apoptosis associated with ER stress is one of the predominant mechanisms of osteoporosis pathogenesis [11–14]. In stressed osteoblasts, endocrine function, including the production of bone formation hormones (e.g., osteopontin and osteocalcin), is impaired [15, 16]. Under stress conditions, ROS (e.g. H2O2) have been identified as key detrimental messengers. Moreover, ROS have also been associated with ER stress in other pathological conditions [17–19]. Numerous studies have evaluated the role of ROS and ER stress in bone development [3, 20–22]. Therefore, the identification of interventions that can control ROS-associated ER stress is important for preventing and treating bone disease.

The placenta is an organ found exclusively in women during pregnancy that supplies nutrients and oxygen to the developing fetus. The nutritional substances and vitamins therein can be extracted in the form of porcine placenta hydrolysates (PPHs). PPHs contain beneficial bioactive components that inhibit aging, sunburns, and oxidation [23, 24]. PPHs have also been used for wound healing in Korean folk medicine [25, 26] and have been demonstrated to exert immunomodulatory effects [27, 28]. However, the effect of PPHs on bone formation remains unclear. To determine the role of PPHs in the endocrine system, it is important to determine the effects of PPHs on osteoblasts, a representative endocrine cell associated with stress conditions. The aim of our study was to evaluate the effects of PPHs on H2O2-induced oxidative damage and the related ER stress in MC3T3-E1 osteoblastic cells. We found that PPHs regulate oxidative ER stress and the associated activation of antioxidants, thus enhancing differentiation of MC3T3-E1 osteoblastic cells in the presence of H2O2.

Methods

Materials

PPHs were purchased from Codebio Inc. (Cheonan, Republic of Korea). Hydrogen peroxide and thapsigargin were obtained from Sigma Chemical Company (St. Louis, MO, USA). Caspase-3 and -12 activity kits were obtained from BioVision (Mountain View, CA, USA). All other reagents used were of analytical grade and were generally obtained from Sigma.

Extraction and quantitation of PPHs using HPLC-DAD

PPHs were purchased from Codebio Inc. (Cheonan, Republic of Korea). Placentas were thawed using a defroster and then washed with saline at 16 °C to remove blood and cords. Placentas were hydrolyzed using papain, bromelain, pronase, and Alcalase at 70 ± 0.1 °C for 2 days (pH 4.5–6.0). Next, hydrolytic enzymes were inactivated at 100 ± 0.1 °C for 30 min and the resultant hydrolysates were filtered. The lipids were then removed by mixing with calcium and phosphate salts and by filtering the insoluble particulate matter. Finally, the hydrolysates were adjusted to pH 7.0 ± 0.2 using calcium and phosphate salts. Hydrolysates were mixed with AccQ-Fluor buffer and Acc-Fluor reagent (Waters Corporation, Milford, MA, USA), after which the mixture was heated at 80 °C. An aliquot of the sample was filtered and injected into an AccQ-Tag column (150 × 2.1 mm, 3 μm particle size; Waters Corporation, Milford, MA, USA) in an HPLC instrument for chromatographic separation. A gradient mixture of AccQ-Tag Eluent (A) and acetonitrile (B) was used as the mobile phase at a flow rate of 1 mL/min at 30 °C. The initial eluent was 100 % A, which linearly decreased to 67 % A over 33 min. The eluent was switched to 100 % B for 3 min and then switched back to 100 % A for 26 min. Amino acids were detected using a fluorescence detector at excitation and emission wavelengths of 250 and 395 nm, respectively.

Cell culture and viability analysis

The murine calvaria-derived MC3T3-E1 osteoblast-like cell line (4 to 10 passages) was purchased from the American Type Culture Collection (ATCC; Manassas, VA, USA). Cells were seeded at 1 × 105 cells/mL and maintained in minimum essential medium (α-MEM) supplemented with 10 % fetal bovine serum (FBS) and penicillin-streptomycin (Invitrogen). Cells were incubated at 37 °C in a 95 % air/5 % CO2 atm. Cell viability was detected using a trypan blue exclusion assay. Briefly, MC3T3-E1 cells (5 × 104 cells/well) were incubated in 12-well plates overnight and treated for 24 h with drugs in medium containing 10 % serum. Cells were washed with sterile phosphate-buffered saline (PBS), treated with 0.25 % trypsin-EDTA (GIBCO BRL), and harvested. Cells were diluted in 0.1 % trypan blue (GIBCO BRL) and then counted under a light microscope.

Immunoblotting

For immunoblotting, MC3T3-E1 osteoblastic cells were lysed with extraction buffer. Proteins in the resultant lysates (40 μg) were resolved on a polyacrylamide gel and transferred to a nitrocellulose membrane. The blots were probed overnight at 4 °C with primary antibodies, washed, and probed again with species-specific secondary antibodies coupled to horseradish peroxidase (GE Healthcare, Piscataway, NJ, USA). Chemiluminescence reagents (GE Healthcare) were used for detection. Primary antibodies consisted of rabbit anti-GADD153/C/EBP homologous protein (CHOP), rabbit-anti-PERK, rat anti-GRP78, rabbit anti-ATF6α, mouse anti-eIF2α, mouse anti-β-actin (Santa Cruz Biotechnologies, Inc., Santa Cruz, CA, USA), rabbit anti-IRE1α, and rabbit anti-p-eIF2 (Cell Signaling Technologies, Inc., Danvers, MA, USA).

Measurement of caspase-3 activity

To analyze caspase-3 activity, pellets were resuspended in extraction buffer [25 mM HEPES (pH 7.4), 0.1 % Triton X-l00, 10 % glycerol, 5 mM DTT] and spun by centrifugation at 13,000 rpm at 4 °C for 30 min. Soluble protein (40 μg) was mixed with 100 μM caspase-3-specific substrate Ac-DEVD-AFC (Sigma-Aldrich) and incubated at 37 °C. Caspase-3 activity was analyzed by monitoring fluorogenic AFC release at 37 °C. Substrate cleavage was monitored at 405 nm using a SPECTRAmax 340 microplate reader and analyzed using SOFTmax PRO software (Molecular Devices, Sunnyvale, CA, USA).

Measurement of caspase-12 activity

To analyze caspase-12 activity, pellets were measured by detecting free AFC cleavage by caspase-12-specific substrates. These experiments were performed with a caspase-12 Assay Kit (Biovision, San Francisco, CA, USA). After the lysates were incubated with ATAD-AFC for 2 h at 37 °C, the absorbance of each sample was analyzed at 505 nm.

Measurement of alkaline phosphatase activity

To analyze ALP activity, cells were treated with Krebs (control), PPHs (100 μg/mL), H2O2 (400 μM), and in the presence or absence of 100 μg/mL PPHs. After treatment for 4 h, cells were lysed. The amount of ALP activity and the protein concentration were measured in each supernatant using an ALP activity assay kit (Cell Biolabs, San Diego, CA, USA).

RT-PCR

The mRNA levels of ALP, osteocalcin, Runx2, osterix, and GAPDH were determined using a PrimeScript™ RT reagent Kit (TaKaRa Bioscience, Kyoto, Japan). The sequences of the primers used for RT-PCR were as follows: ALP, forward primer: 5′-CCATGGTAGATTACGCTCACA-3′, reverse primer: 5′-ATGGAGGATTCCAGATACAGG-3′; osteocalcin, forward primer: 5′-AGCTATCAGACCAGTATGGCT-3′, reverse primer: 5′-TTTTGGAGCTGCTGTGACATC-3′; Runx2, forward primer: 5′-CTCAGTGATTTAGGGCGCATT-3′, reverse primer: 5′-AGGGGTAAGACTGGTCATAGG-3′; Osterix, forward primer: 5′- CGGGTCAGGTACAGTG-3′, reverse primer: 5′- ACCATGACGACAAGGG-3′; and GAPDH, forward primer: 5′-ATCACCATCTTCCAGGAG-3′, reverse primer: 5′-ATGGACTGTGGTCATGAG-3′. Reverse transcription was performed by incubating the reactions at 37 °C for 15 min and then at 85 °C for 5 s. For polymerase chain reaction amplification, an initial denaturation step was performed at 94 °C for 3 min, followed by annealing at 55 °C for 20 s and elongation at 72 °C for 45 s. In total, 35 cycles were performed.

NADPH oxidase activity assay

Cells were seeded in six-well plates and cultured for 48 h. Next, the cells were treated with 100 μM H2O2 for 6 h in the presence or absence of 100 μg/mL PPHs. NADPH oxidase activity was determined based on superoxide-induced lucigenin photoemission as described by Rao and Maddala et al. [29]. Enzymatic assays were performed in a final volume of 0.2 ml containing 50 mM phosphate buffer (pH 7.0), 1 mM EGTA, 150 mM sucrose, 0.5 mM lucigenin, 0.1 mM NADPH, and cell lysis solution. Enzymatic reactions were initiated by the addition of lucigenin. Photoemission, expressed as relative light units, was measured every minute for 10 min using a luminometer. Assays were performed in the dark at room temperature with all appropriate controls.

Superoxide dismutase (SOD) activity assay

Cells were seeded in six-well plates and cultured for 48 h. The cells were then treated with 100 μM H2O2 for 6 h in the presence or absence of 100 μg/mL PPHs. Next, cells were harvested and the level of SOD activity was determined using a SOD assay kit (k335-100, Biovision) according to the manufacturer’s instructions.

DCFDA assay (ROS production)

The cellular ROS level was measured by following the protocol described by Badham et al. [30]. Briefly, cells were treated with 100 μM H2O2 at 37 °C in the presence or absence of 100 μg/mL PPHs for 6 h. Next, cells were incubated with 10 μM 2′, 7′-dichlorofluorescein diacetate (DCFDA) at 37 °C for an additional 30 min. The fluorescence intensity of 2′,7′-dichlorofluorescein, a product of the reaction between DCFDA and cellular ROS, was analyzed using a fluorescence reader (SpectraMax 190, Molecular Devices, Sunnyvale, CA, USA). Data were normalized to the H2O2 absorbance values.

Statistical analysis

Results are presented as means ± standard errors of the mean (SEMs) for multiple wells tested in at least three separate experiments. MicroCal Origin software (Northampton, MA, USA) was used for statistical calculations. Differences were tested for significance using one-way analysis of variance (ANOVA) with Duncan’s multiple range test.

Results

PPHs protect against H2O2-induced cell death in MC3T3-E1 osteoblastic cells

We first determined if PPHs exert concentration-dependent effects on cell viability. Treatment with PPHs for 6 h at concentrations ranging from 25 to 100 μg/mL did not have any significant effect on cell survival (Fig. 1a). However, treatment of cells for 6 h with 100, 200, or 400 μM H2O2 markedly increased cell death in a concentration-dependent manner (Fig. 1b). Interestingly, treatment of cells with 400 μM H2O2 and 25, 50, or 100 μg/mL PPHs markedly affected cell survival in a concentration- and time-dependent manner (Fig. 1c and d). Moreover, treatment with 100 μg/mL PPHs for 30 min significantly protected cells against H2O2-induced (400 μM) cell damage. These findings suggest that PPHs significantly protect MC3T3-E1 osteoblastic cells.

Fig. 1
figure1

PPHs regulate H2O2-induced cell death in MC3T3-E1 osteoblastic cells. a To test the cell viability of PPHs in MC3T3-E1 cells, cells were treated with 0, 25, 50, or 100 μg/mL PPHs only for 6 h. Cell viability was estimated via the trypan blue exclusion test. Untreated cells were used as the control. b To test the cell viability of H2O2 in MC3T3-E1 cells, cells were treated with 0, 100, 200, or 400 μM H2O2 only for 6 h. Cell viability was estimated via the trypan blue exclusion test. Untreated cells were used as the control. c Cells were treated with 0, 25, 50, or 100 μg/mL PPHs in the presence or absence of 400 μM H2O2 for 6 h, and cell survival was assessed. d Cells were exposed to 400 μM H2O2 in the presence or absence of 100 μg/mL PPHs for 0, 2, 4, or 6 h, after which cell viability was assessed. * p < 0.05 versus cells treated with H2O2 alone (n = 3). PPHs porcine placenta hydrolysates

Full size image

PPHs protect against H2O2-induced apoptosis in MC3T3-E1 osteoblastic cells

To evaluate whether PPHs could protect against ER stress in osteoblasts, cells were treated with 400 μM H2O2 for 6 h or 0.1 μM Tg (thapsigargin, a Ca2+-ATPase inhibitor) for 24 h to induce ER stress. To investigate the ER stress response, the levels of GRP78, CHOP, p-PERK, p-eIF2α, p-IRE1-α, and ATF6α were analyzed by immunoblotting. The levels of these proteins were all significantly increased in cells treated with 400 μM H2O2 or 0.1 μM Tg. However, treatment with PPHs inhibited this upregulation of GRP78, CHOP p-PERK, p-eIF2α, p-IRE1-α, and ATF6α (Fig. 2a and b). Moreover, PPHs inhibited H2O2-induced cell injury. Apoptosis levels were measured by flow cytometry and are expressed in units of mean fluorescence intensity. As shown in Fig. 3a-b, PPHs protected osteoblasts against H2O2-induced apoptosis. H2O2 treatment also induced nuclear condensation and fragmentation, characteristics of apoptosis. Pretreatment with PPHs markedly attenuated these effects (Fig. 3a). Moreover, the apoptosis level was 31.55 ± 1.02 % after H2O2 treatment for 6 h, whereas the apoptosis level in the PPHs group was 15.33 ± 2.1 % (Fig. 3b). These results confirm the protective effects of PPHs against H2O2-induced apoptosis in cells. Caspase-12 activation is associated with apoptosis [31]. Thus, we evaluated the effect of PPHs on caspase-12 activation. We found that caspase-12 activity was increased significantly after H2O2 treatment, whereas treatment with PPHs markedly reduced this H2O2-induced increase in caspase-12 activity (Fig. 3c). Next, we investigated caspase-3 activation. We found that H2O2 increased caspase-3 activation, whereas this increase was blocked by PPH treatment (Fig. 3d). Cells were exposed to H2O2 in the absence or presence of PPHs for 2, 4, and 6 h, after which the levels of apoptosis-related proteins were analyzed. H2O2 significantly increased the levels of caspase-12, caspase-3, and Bax in a time-dependent manner; in contrast, treatment with PPHs markedly reduced the protein levels of caspase-12, caspase-3, and Bax protein in MC3T3-E1 cells (Fig. 3e).

Fig. 2
figure2

PPHs decrease the H2O2-induced ER stress response in MC3T3-E1 osteoblastic cells. a Cells were exposed to 400 μM H2O2 or 0.1 μM Tg and 0, 25, 50, or 100 μg/mL PPHs for 6 h. Immunoblotting was performed using the indicated antibodies. b Cells were exposed to 400 μM H2O2 in the presence or absence of 100 μg/mL PPHs for 0, 2, 4, or 6 h. Immunoblotting was performed using the indicated antibodies. Blots are representative of three independent experiments. * p < 0.05 versus cells treated with H2O2 alone (n = 3). PPHs porcine placenta hydrolysates, Tg thapsigargin

Full size image
Fig. 3
figure3

PPHs protect against H2O2-induced apoptosis in MC3T3-E1 osteoblastic cells. a Apoptosis was detected by Hoechst dye staining and quantified based on nuclear condensation or fragmentation (right). Representative pictures are shown from three independent experiments. Images were taken at a magnification of 400×. Scale bar, 20 μm. b Cells were stained with FITC-conjugated Annexin V and PI, followed by flow cytometric analysis. c Caspase-12 activity was analyzed in cells treated for 0, 12, 24, 36 or 48 h with 400 μM H2O2 in the presence or absence of 100 μg/mL PPHs. d Caspase-3 activity was measured in cells that were treated for 6 h with 400 μM H2O2 in the presence or absence of 100 μg/mL PPHs. e Cells were treated for 0, 2, 4, or 6 h with 400 μM H2O2 in the presence or absence of 100 μg/mL PPHs. Immunoblotting was performed using the indicated antibodies. Representative blots are shown from three independent experiments. Bottom panel, quantitative immunoblot data (n = 4). * p < 0.05 versus cells treated with H2O2 alone. PPHs porcine placenta hydrolysates

Full size image

PPHs attenuate H2O2-mediated inhibition of ALP activity

To investigate the effect of PPHs on osteoblast differentiation, we investigated the mRNA level and activity of ALP in MC3T3-E1 cells. Treatment with 400 μM H2O2 for 6 h significantly decreased the mRNA level of ALP. However, treatment with PPHs markedly alleviated H2O2-mediated downregulation of ALP. Similarly, treatment for 6 h with 400 μM H2O2 markedly reduced ALP activity in cells. However, treatment with 100 μg/mL PPHs attenuated this effect of H2O2 (Fig. 4b).

Fig. 4
figure4

PPHs alleviate H2O2-mediated inhibition of ALP activity in MC3T3-E1 osteoblastic cells. a ALP mRNA levels in cells treated for 6 h with 400 μM H2O2 in the presence or absence of 100 μg/mL PPHs were analyzed by RT-PCR. Representative bands are shown from three independent experiments. Quantitative analysis of RNA expression was also performed. b ALP activity levels were analyzed in cells treated with 400 μM H2O2 in the presence or absence of 100 μg/mL PPHs (n = 3). * p < 0.05 versus cells treated with H2O2 alone. PPHs porcine placenta hydrolysates

Full size image

PPHs attenuate H2O2-induced downregulation of osteocalcin, Runx2, and osterix

To investigate the effects of PPHs on bone formation proteins, we investigated the mRNA levels of osteocalcin, Runx2 [32], and osterix [33]. Treatment for 6 h with 400 μM H2O2 markedly decreased the mRNA level of osteocalcin, whereas this change was markedly reversed by PPHs. Similarly, H2O2 markedly downregulated the mRNA levels of Runx2 and osterix (Fig. 5b and c). However, PPHs markedly attenuated this H2O2-mediated downregulation of Runx2 and osterix.

Fig. 5
figure5

PPHs reverse the effects of H2O2 on the mRNA expression of osteocalcin, Runx2, and osterix in MC3T3-E1 osteoblastic cells. Osteocalcin (a), Runx2 (b), and Osterix (c) expression levels in cells treated for 6 h with 400 μM H2O2 in the presence or absence of 100 μg/mL PPHs were analyzed by RT-PCR. Representative bands are shown from three independent experiments. Quantitative analysis of RNA expression was also performed. * p < 0.05 versus cells treated with H2O2 alone. PPHs porcine placenta hydrolysates

Full size image

PPHs affect ROS release, NADPH oxidase, and SOD activity in MC3T3-E1 osteoblastic cells

To evaluate the antioxidant effects of PPHs, we investigated the effect of PPHs on H2O2-mediated ROS production. We found that treatment with 400 μM H2O2 for 2, 4, or 6 h markedly increased ROS production. However, treatment with 100 μg/mL PPHs for 6 h markedly attenuated this H2O2–mediated increase in intracellular ROS (Fig. 6a). Next, we examined the effect of PPHs on the activity of NADPH oxidase, an enzyme that generates ROS. As shown in Fig. 6b, PPHs reduced H2O2-induced NADPH oxidase activity. These findings suggest that PPHs have antioxidant effects on osteoblasts. Next, we investigated the effect of PPHs on SOD activity. H2O2 treatment markedly inhibited SOD activity, whereas this effect was also alleviated by PPHs (Fig. 6c).

Fig. 6
figure6

PPHs regulate ROS release, NADPH oxidase, and SOD activity in MC3T3-E1 osteoblastic cells. a ROS production was analyzed in cells treated for 6 h with 400 μM H2O2 in the presence or absence of 100 μg/mL PPHs by the DCF-DA assay. NADPH oxidase (b) and SOD activities (c) were assessed in cells treated for 6 h with 400 μM H2O2 in the presence or absence of 100 μg/mL PPHs. Representative bands are shown from three independent experiments. Quantitative analysis of RNA expression was also performed. * p < 0.05 versus cells treated with H2O2 alone. PPHs, porcine placenta hydrolysates

Full size image

Discussion

In this study, we found that PPHs protect MC3T3-E1 cells against H2O2-induced cell death and suppression of differentiation. H2O2-induced oxidative stress is known to lead to pathological ER stress. We found that PPHs, presumably via their antioxidant effects, protected MC3T3-E1 osteoblastic cells against H2O2-induced ER stress and ROS production. Moreover, PPHs significantly reversed H2O2-mediated downregulation of osteocalcin and two related proteins involved in bone formation, namely osterix and Runx2.

Reactive oxygen species (ROS) are generated by many environmental agents and have been implicated in the pathogenesis of various diseases, including osteoporosis [34]. Reduced bone formation by osteoblasts may cause osteoporosis to develop; moreover, the rate of osteoblast apoptosis regulates bone formation [1, 2, 35, 36]. ER stress has been implicated as an important factor in apoptosis due to various causes, including osteoblast apoptosis during the development of osteoporosis [11, 13, 14, 37]. The placenta has been studied for its potential to improve skin care, metabolic functions, and strengthen immune function [23]. However, it has remained unclear whether the placenta can protect osteoblasts from H2O2-induced ER stress and apoptosis. Here we evaluated the effects of PPHs on H2O2-induced ER stress and apoptosis in osteoblasts. ROS production is known to decrease bone formation by osteoblastic cells by suppressing the differentiation of osteoblast progenitors and the calcification process [38]. Therefore, decreased bone formation is strongly associated with enhanced oxidative stress and significantly decreased plasma levels of antioxidants in elderly persons with osteoporosis [39, 40]. In this study, H2O2 induced cell death, ER stress, and caspase-mediated apoptosis (Figs. 1, 2 and 3). However, PPH treatment prevented caspase activation, thus reducing the amount of apoptosis in response to ER stress. ER stress was recently reported to be involved in the induction of apoptosis during osteoporosis [11, 12, 14, 37]. ER stress is activated by the accumulation of unfolded proteins and alterations in calcium homeostasis [6–8]. Recent studies have also shown that ER stress-induced apoptosis of osteoblasts contributes to the development of osteoporosis [11–14, 37]. We found that ER stress was decreased in MC3T3-E1 cells (Fig. 2). However, treatment with PPHs increased osteoblast viability during periods of ER stress. Moreover, PPHs inhibited osteoblast apoptosis in response to ER stress. These results demonstrate that PPHs can protect osteoblasts from ER stress-induced apoptosis.

Caspases are the most prominent mediators of apoptosis. However, it is not clear if activated caspase-12 or caspase-3 plays an important role in H2O2-induced apoptosis [41]. In this study, we found that PPHs reversed the H2O2-induced activation of caspase-12 and caspase-3 (Fig. 3). These results demonstrate that PPHs can protect osteoblasts from caspase-mediated, H2O2-induced apoptosis.

H2O2-induced apoptosis is primary mediated by ROS production. We evaluated the protective effects of PPHs and found that they decreased H2O2-induced ROS release (Fig. 6). We also found that PPHs markedly inhibited NADPH oxidase activity. NADPH oxidase is important because it activates ROS-generating enzymes. PPHs also alleviated H2O2-mediated inhibition of SOD activity. The enhanced SOD activity observed upon treatment with PPHs may result in the scavenging of excessive superoxides derived from oxidative stress, thus ameliorating H2O2-induced cell death.

We also evaluated the effects of PPHs on osteoblastic differentiation. ALP is a primary marker of osteoblast differentiation. We found that H2O2 markedly downregulated ALP expression and that this effect was alleviated by PPHs (Fig. 4). Our data thus indicate that PPHs stimulate osteoblast differentiation. Furthermore, we also analyzed the mRNA levels of Runx2, osterix, and osteocalcin. Osteocalcin is a major protein produced by osteoblasts during bone formation. Osteocalcin expression is regulated by Runx2 and osterix levels [32, 42]. Therefore, we assessed the expression of osterix and Runx2 after treatment with PPHs and/or H2O2 (Fig. 5). We found that PPHs markedly reversed H2O2-mediated downregulation of osterix and Runx2 expression. These findings suggest that PPHs upregulate osteocalcin, osterix, and Runx2 expression.

It was beyond the scope of the present study to identify the active component(s) in PPHs. However, recent studies have suggested that dietary arginine and lysine may play an important role in bone development, growth, and modeling [43]. Moreover, arginine is thought to alleviate metabolic disturbances in calcium absorption, growth, dentition, and decalcification [44]. PPHs are known to contain high levels of arginine and other essential amino acids. Thus, our findings provide evidence that PPHs may have potential therapeutic value for treating bone metabolism disturbances in osteoblasts.

Conclusions

Our findings suggest that PPHs, presumably via their antioxidant effects, protect MC3T3-E1 osteoblasts against H2O2-induced ER stress by suppressing ROS production. Furthermore, PPHs regulate oxidative stress-induced osteoporosis. Cumulatively, our findings suggest that PPHs may have potential therapeutic value for treating bone formation disturbances.

Abbreviations

ALP:

Alkaline Phosphatase

ER:

Endoplasmic Reticulum

H2O2 :

Hydrogen Peroxide

PPHs:

Porcine Placenta Hydrolysates

ROS:

Reactive Oxygen Species

Tg:

Thapsigargin

References

  1. 1.

    Karsenty G, Wagner EF. Reaching a genetic and molecular understanding of skeletal development. Dev Cell. 2002;2(4):389–406.

    CAS  Article  PubMed  Google Scholar 

  2. 2.

    Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest. 2005;115(12):3318–25.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  3. 3.

    Wu Y, Yang M, Fan J, Peng Y, Deng L, Ding Y, Yang R, Zhou J, Miao D, Fu Q. Deficiency of osteoblastic Arl6ip5 impaired osteoblast differentiation and enhanced osteoclastogenesis via disturbance of ER calcium homeostasis and induction of ER stress-mediated apoptosis. Cell Death Dis. 2014;5:e1464.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  4. 4.

    Hock JM, Krishnan V, Onyia JE, Bidwell JP, Milas J, Stanislaus D. Osteoblast apoptosis and bone turnover. J Bone Miner Res Off J Am Soc Bone Miner Res. 2001;16(6):975–84.

    CAS  Article  Google Scholar 

  5. 5.

    Downey PA, Siegel MI. Bone biology and the clinical implications for osteoporosis. Phys Ther. 2006;86(1):77–91.

    PubMed  Google Scholar 

  6. 6.

    Schroder M. Endoplasmic reticulum stress responses. Cell Mol Life Sci. 2008;65(6):862–94.

    CAS  Article  Google Scholar 

  7. 7.

    Boyce M, Yuan J. Cellular response to endoplasmic reticulum stress: a matter of life or death. Cell Death Differ. 2006;13(3):363–73.

    CAS  Article  PubMed  Google Scholar 

  8. 8.

    Hotamisligil GS. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell. 2010;140(6):900–17.

    CAS  Article  PubMed  Google Scholar 

  9. 9.

    Hasnain SZ, Lourie R, Das I, Chen AC, McGuckin MA. The interplay between endoplasmic reticulum stress and inflammation. Immunol Cell Biol. 2012;90(3):260–70.

    CAS  Article  PubMed  Google Scholar 

  10. 10.

    Yamada H, Nakajima T, Domon H, Honda T, Yamazaki K. Endoplasmic reticulum stress response and bone loss in experimental periodontitis in mice. J Periodontal Res. 2015;50(4):500–8.

    CAS  Article  PubMed  Google Scholar 

  11. 11.

    Park SJ, Kim KJ, Kim WU, Oh IH, Cho CS. Involvement of endoplasmic reticulum stress in homocysteine-induced apoptosis of osteoblastic cells. J Bone Miner Metab. 2012;30(4):474–84.

    CAS  Article  PubMed  Google Scholar 

  12. 12.

    Tang CH, Chiu YC, Huang CF, Chen YW, Chen PC. Arsenic induces cell apoptosis in cultured osteoblasts through endoplasmic reticulum stress. Toxicol Appl Pharmacol. 2009;241(2):173–81.

    CAS  Article  Google Scholar 

  13. 13.

    Lisse TS, Thiele F, Fuchs H, Hans W, Przemeck GK, Abe K, Rathkolb B, Quintanilla-Martinez L, Hoelzlwimmer G, Helfrich M, et al. ER stress-mediated apoptosis in a new mouse model of osteogenesis imperfecta. PLoS Genet. 2008;4(2):e7.

    Article  PubMed  PubMed Central  Google Scholar 

  14. 14.

    He L, Lee J, Jang JH, Sakchaisri K, Hwang J, Cha-Molstad HJ, Kim KA, Ryoo IJ, Lee HG, Kim SO, et al. Osteoporosis regulation by salubrinal through eIF2alpha mediated differentiation of osteoclast and osteoblast. Cell Signal. 2013;25(2):552–60.

    CAS  Article  PubMed  Google Scholar 

  15. 15.

    Raggatt LJ, Partridge NC. Cellular and molecular mechanisms of bone remodeling. J Biol Chem. 2010;285(33):25103–8.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  16. 16.

    Raisz LG. Physiology and pathophysiology of bone remodeling. Clin Chem. 1999;45(8 Pt 2):1353–8.

    CAS  PubMed  Google Scholar 

  17. 17.

    Aggarwal BB. Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. Annu Rev Nutr. 2010;30:173–99.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  18. 18.

    Bhandari P, Song M, Dorn 2nd GW. Dissociation of mitochondrial from sarcoplasmic reticular stress in Drosophila cardiomyopathy induced by molecularly distinct mitochondrial fusion defects. J Mol Cell Cardiol. 2015;80:71–80.

    CAS  Article  PubMed  Google Scholar 

  19. 19.

    Cheng AC, Tsai ML, Liu CM, Lee MF, Nagabhushanam K, Ho CT, Pan MH. Garcinol inhibits cell growth in hepatocellular carcinoma Hep3B cells through induction of ROS-dependent apoptosis. Food Funct. 2010;1(3):301–7.

    CAS  Article  PubMed  Google Scholar 

  20. 20.

    Guo YS, Sun Z, Ma J, Cui W, Gao B, Zhang HY, Han YH, Hu HM, Wang L, Fan J, et al. 17beta-Estradiol inhibits ER stress-induced apoptosis through promotion of TFII-I-dependent Grp78 induction in osteoblasts. Lab Invest. 2014;94(8):906–16.

    CAS  Article  PubMed  Google Scholar 

  21. 21.

    Hamamura K, Yokota H. Stress to endoplasmic reticulum of mouse osteoblasts induces apoptosis and transcriptional activation for bone remodeling. FEBS Lett. 2007;581(9):1769–74.

    CAS  Article  PubMed Central  Google Scholar 

  22. 22.

    Xiong Z, Jiang R, Zhang P, Han X, Guo FJ. Transmission of ER stress response by ATF6 promotes endochondral bone growth. J Orthop Surg Res. 2015;10:141.

    Article  PubMed Central  Google Scholar 

  23. 23.

    Togashi S, Takahashi N, Iwama M, Watanabe S, Tamagawa K, Fukui T. Antioxidative collagen-derived peptides in human-placenta extract. Placenta. 2002;23(6):497–502.

    CAS  Article  PubMed  Google Scholar 

  24. 24.

    Yamasaki M, Hasegawa S, Takahashi H, Kobayashi Y, Sakai C, Ashizawa Y, Asai Y, Kanzaki M, Fukui T. Placental extracts induce the expression of antioxidant enzyme genes and suppress melanogenesis in B16 melanoma cells. Nat Prod Res. 2015;29(22):2103–6.

    CAS  Article  PubMed  Google Scholar 

  25. 25.

    Hong JW, Lee WJ, Hahn SB, Kim BJ, Lew DH. The effect of human placenta extract in a wound healing model. Ann Plast Surg. 2010;65(1):96–100.

    CAS  Article  PubMed  Google Scholar 

  26. 26.

    Nath S, Bhattacharyya D. Cell adhesion by aqueous extract of human placenta used as wound healer. Indian J Exp Biol. 2007;45(8):732–8.

    PubMed  Google Scholar 

  27. 27.

    Fang XP, Xia WS, Sheng QH, Wang YL. Purification and characterization of an immunomodulatory Peptide from bovine placenta water-soluble extract. Prep Biochem Biotechnol. 2007;37(3):173–84.

    CAS  Article  PubMed  Google Scholar 

  28. 28.

    Lee KH, Park HJ, Seo HG, Kim JH, Lim GS, Lee WY, Kim NH, Kim JH, Lee JH, Jung HS, et al. Immune modulation effect of porcine placenta extracts in weaned the pig. J Anim Sci. 2013;91(5):2405–13.

    CAS  Article  PubMed  Google Scholar 

  29. 29.

    Zayzafoon M. Calcium/calmodulin signaling controls osteoblast growth and differentiation. J Cell Biochem. 2006;97(1):56–70.

    CAS  Article  PubMed  Google Scholar 

  30. 30.

    Badham HJ, LeBrun DP, Rutter A, Winn LM. Transplacental benzene exposure increases tumor incidence in mouse offspring: possible role of fetal benzene metabolism. Carcinogenesis. 2010;31(6):1142–8.

    CAS  Article  PubMed  Google Scholar 

  31. 31.

    Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA, Yuan J. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature. 2000;403(6765):98–103.

    CAS  Article  PubMed  Google Scholar 

  32. 32.

    Gersbach CA, Byers BA, Pavlath GK, Garcia AJ. Runx2/Cbfa1 stimulates transdifferentiation of primary skeletal myoblasts into a mineralizing osteoblastic phenotype. Exp Cell Res. 2004;300(2):406–17.

    CAS  Article  PubMed  Google Scholar 

  33. 33.

    Komori T. Regulation of osteoblast differentiation by transcription factors. J Cell Biochem. 2006;99(5):1233–9.

    CAS  Article  PubMed  Google Scholar 

  34. 34.

    Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature. 2000;408(6809):239–47.

    CAS  Article  PubMed  Google Scholar 

  35. 35.

    Rodan GA, Martin TJ. Therapeutic approaches to bone diseases. Science. 2000;289(5484):1508–14.

    CAS  Article  PubMed  Google Scholar 

  36. 36.

    Weinstein RS, Manolagas SC. Apoptosis and osteoporosis. Am J Med. 2000;108(2):153–64.

    CAS  Article  PubMed  Google Scholar 

  37. 37.

    Hino S, Kondo S, Yoshinaga K, Saito A, Murakami T, Kanemoto S, Sekiya H, Chihara K, Aikawa Y, Hara H, et al. Regulation of ER molecular chaperone prevents bone loss in a murine model for osteoporosis. J Bone Miner Metab. 2010;28(2):131–8.

    CAS  Article  PubMed  Google Scholar 

  38. 38.

    Hosoya S, Suzuki H, Yamamoto M, Kobayashi K, Abiko Y. Alkaline phosphatase and type I collagen gene expressions were reduced by hydroxyl radical-treated fibronectin substratum. Mol Genet Metab. 1998;65(1):31–4.

    CAS  Article  PubMed  Google Scholar 

  39. 39.

    Basu S, Michaelsson K, Olofsson H, Johansson S, Melhus H. Association between oxidative stress and bone mineral density. Biochem Biophys Res Commun. 2001;288(1):275–9.

    CAS  Article  PubMed  Google Scholar 

  40. 40.

    Maggio D, Barabani M, Pierandrei M, Polidori MC, Catani M, Mecocci P, Senin U, Pacifici R, Cherubini A. Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study. J Clin Endocrinol Metab. 2003;88(4):1523–7.

    CAS  Article  PubMed  Google Scholar 

  41. 41.

    Singh M, Sharma H, Singh N. Hydrogen peroxide induces apoptosis in HeLa cells through mitochondrial pathway. Mitochondrion. 2007;7(6):367–73.

    CAS  Article  PubMed  Google Scholar 

  42. 42.

    Hassan MQ, Javed A, Morasso MI, Karlin J, Montecino M, van Wijnen AJ, Stein GS, Stein JL, Lian JB. Dlx3 transcriptional regulation of osteoblast differentiation: temporal recruitment of Msx2, Dlx3, and Dlx5 homeodomain proteins to chromatin of the osteocalcin gene. Mol Cell Biol. 2004;24(20):9248–61.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  43. 43.

    Sahin K, Onderci M, Sahin N, Balci TA, Gursu MF, Juturu V, Kucuk O. Dietary arginine silicate inositol complex improves bone mineralization in quail. Poult Sci. 2006;85(3):486–92.

    CAS  Article  PubMed  Google Scholar 

  44. 44.

    Fiore CE, Pennisi P, Cutuli VM, Prato A, Messina R, Clementi G. L-arginine prevents bone loss and bone collagen breakdown in cyclosporin A-treated rats. Eur J Pharmacol. 2000;408(3):323–6.

    CAS  Article  PubMed  Google Scholar 

Download references

Acknowledgments/Funding

This study was supported by a grant from Chonbuk National University Hospital (to JHK) and a grant from the National Research Foundation (2015R1A2A1A13001849).

Availability of data and materials

All datasets supporting the conclusions of this article are included within the article.

Authors’ contributions

HYL and JHK participated in the research design. HYL and HJC carried out the experiments, analyzed the data, and wrote the paper. SYP and JHK provided funding and supervised the study. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Not applicable.

Ethics approval and consent to participate

Not applicable.

Author information

Affiliations

  1. Department of Pharmacology and Institute of Drug Development, Chonbuk National University, Jeonju, 560-182, Republic of Korea

    Hwa-Young Lee & Han-Jung Chae

  2. CODEBIO CO., LTD, Busong 1gil 62, Jiksan-eup, Seobuk-gu, Cheonan, Chungnam, 331-815, Republic of Korea

    Sun-Young Park

  3. Department of Obstetrics and Gynecology, Institute for Medical Sciences, Chonbuk National University Medical School, Jeonju, 560-182, Republic of Korea

    Jong-Hyun Kim

Authors
  1. Hwa-Young Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Han-Jung Chae
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sun-Young Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jong-Hyun Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jong-Hyun Kim.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Lee, H., Chae, H., Park, S. et al. Porcine placenta hydrolysates enhance osteoblast differentiation through their antioxidant activity and effects on ER stress. BMC Complement Altern Med 16, 291 (2016). https://doi.org/10.1186/s12906-016-1274-y

Download citation

Keywords

  • Osteoporosis
  • Oxidative damage
  • Alkaline phosphatase
  • Apoptosis
  • ROS

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us